Diretriz de prática clínica com recomendações estratificadas pelo risco | Inibidores de PCSK9 e ezetimibe para redução de eventos cardiovasculares.

PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations – The BMJ

Ver também: PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysis – The BMJ

Comunicado de imprensa: Experts recommend additional cholesterol lowering drugs for adults at high heart disease risk – British Medical Journal